{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["84(4)"],"submitter":["Wada H"],"pubmed_abstract":["Crohn's disease patients suffer from symptoms originating from small bowel lesions, including strictures. As many of these patients also have a potential risk of surgery, it is important to consider various therapeutic strategies for small bowel lesions. We retrospectively analyzed the therapeutic effects of ustekinumab, interleukin-12 and -23 blocker, for small intestinal lesions and intestinal stenosis in order to contribute to the optimal management of Crohn's disease. Patients who underwent total colonoscopy or small bowel endoscopy before and after the introduction of ustekinumab were enrolled in this study. The colonoscopy findings were evaluated by the simple endoscopic score for Crohn's disease, and small bowel endoscopy findings were evaluated using the modified simple endoscopic "],"journal":["Nagoya journal of medical science"],"pagination":["825-838"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9748316"],"repository":["biostudies-literature"],"pubmed_title":["The effects of ustekinumab on small intestinal lesions and stenotic lesions."],"pmcid":["PMC9748316"],"pubmed_authors":["Kakushima N","Nakayama G","Furukawa K","Nakamura M","Ishikawa T","Ohno E","Kawashima H","Ishigami M","Ishikawa E","Umeda S","Wada H","Murate K","Hattori N","Maeda K","Sawada T","Yamamura T","Honda T"],"additional_accession":[]},"is_claimable":false,"name":"The effects of ustekinumab on small intestinal lesions and stenotic lesions.","description":"Crohn's disease patients suffer from symptoms originating from small bowel lesions, including strictures. As many of these patients also have a potential risk of surgery, it is important to consider various therapeutic strategies for small bowel lesions. We retrospectively analyzed the therapeutic effects of ustekinumab, interleukin-12 and -23 blocker, for small intestinal lesions and intestinal stenosis in order to contribute to the optimal management of Crohn's disease. Patients who underwent total colonoscopy or small bowel endoscopy before and after the introduction of ustekinumab were enrolled in this study. The colonoscopy findings were evaluated by the simple endoscopic score for Crohn's disease, and small bowel endoscopy findings were evaluated using the modified simple endoscopic ","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Nov","modification":"2025-04-18T16:30:54.445Z","creation":"2025-04-07T03:46:12.092Z"},"accession":"S-EPMC9748316","cross_references":{"pubmed":["36544611"],"doi":["10.18999/nagjms.84.4.825"]}}